This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Initial Evidence of the Beneficial Effects of Glutamate-Modulating Agents in the Treatment of Self-Injurious Behavior Associated With Borderline Personality Disorder

Christopher Pittenger, MD, PhD; John H. Krystal, MD; and Vladimir Coric, MD

Published: November 15, 2005

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Self-injurious behavior (SIB) in patients with borderlinepersonality disorder (BPD), especially cutting, represents aserious and often intractable clinical problem.1 There are fewvalidated pharmacologic strategies for managing SIB.1-3 Wedescribe our initial experience using glutamate-modulatingagents in 2 patients with BPD and prominent SIBs.’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 66

Quick Links: Personality Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Letter to the Editor

Stigma Kills Psychiatric Patients and Is Now Killing Clinical Research Too

Robert M. Post, MD, argues that NIMH should abandon the RDoC framework and restore funding for clinical...

Read More...